home / stock / vcel / vcel news


VCEL News and Press, Vericel Corporation From 11/09/22

Stock Information

Company Name: Vericel Corporation
Stock Symbol: VCEL
Market: NASDAQ
Website: vcel.com

Menu

VCEL VCEL Quote VCEL Short VCEL News VCEL Articles VCEL Message Board
Get VCEL Alerts

News, Short Squeeze, Breakout and More Instantly...

VCEL - Vericel GAAP reports Q3 earnings miss; narrows FY22 guidance range below estimates

Vericel press release ( NASDAQ: VCEL ): Q3 GAAP EPS of -$0.14 misses by $0.04 . Revenue of $38.6M (+11.9% Y/Y) misses by $1.3M . MACI ® net revenue of $31.0 million, Epicel ® net revenue of $7.3 million, and NexoBrid ® revenue of $0.2...

VCEL - Vericel Reports Third Quarter 2022 Financial Results

Total Net Product Revenue of $38.6 Million MACI Net Revenue Increased 30% to $31.0 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the spo...

VCEL - Vericel to Report Third-Quarter 2022 Financial Results on November 9, 2022

CAMBRIDGE, Mass., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its third-quarter 2022 financial results on Wednesday, November 9, 2022. Vericel&#x...

VCEL - Vericel Corporation: Stock Has Fallen, But Not Enough To Make This A Buy

Summary MACI is a great product, but even generous peak sales assumptions don’t justify making this a buy. Even if NexoBrid is approved and matches Epicel revenues, it does not change my valuation much. The stock has fallen quite a bit since hitting $60+/share, but it&#...

VCEL - Vericel to Present at the Ladenburg Thalmann Healthcare Conference

CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Chief Financial Officer Joe Mara will present at the upcoming Ladenburg Thalmann Healthcare Confe...

VCEL - Vericel to Present at the Morgan Stanley Global Healthcare and H.C. Wainwright Global Investment Conferences

CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Company leadership will present at the upcoming Morgan Stanley and H.C. Wainwright investor confe...

VCEL - The Bull Market Is Still Alive

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Editor’s Note : John and Wade here – today, we have a special guest issue from InvestorPlace’s own Luke Lango. The markets have slid following the Fed symposium in Jackson Hole over the weekend, and a ...

VCEL - Vericel (VCEL) Q2 2022 Earnings Call Transcript

Image source: The Motley Fool. Vericel (NASDAQ: VCEL) Q2 2022 Earnings Call Aug 03, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Vericel (VCEL) Q2 2022 Earnings Call Transcript

VCEL - Vericel Corporation (VCEL) CEO Nick Colangelo on Q2 2022 Results - Earnings Call Transcript

Vericel Corporation (VCEL) Q2 2022 Earnings Conference Call August 03, 2022 08:30 AM ET Company Participants Eric Burns - Head of Financial Planning and Analysis & Investor Relations Nick Colangelo - President & Chief Executive Officer Joe Mara - Chief Fi...

VCEL - Vericel Corporation 2022 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Vericel Corporation in conjunction with their 2022 Q2 earnings call. For further details see: Vericel Corporation 2022 Q2 - Results - Earnings Call Presentation

Previous 10 Next 10